#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Hepatocellular carcinoma Dementia Alzheimer's type Asthma Dermatitis atopic Breast cancer metastatic Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Von Willebrand's disease Activated PI3 kinase delta syndrome Fallopian tube cancer Eosinophilic oesophagitis Fibrosarcoma metastatic Acute myeloid leukaemia (in remission) Interstitial lung disease Malignant melanoma Autologous haematopoietic stem cell transplant Multifocal motor neuropathy Anti-myelin-associated glycoprotein antibodies positive Hypertriglyceridaemia Brain abscess Cryoglobulinaemia Immunodeficiency common variable More trials…

    Learn about Rare Diseases

    Pleomorphic leiomyosarcoma Pyogenic sterile arthritis pyoderma gangrenosum and acne syndrome – Basic Information Marfan’s syndrome Skin angiosarcoma – Life with Disease Marginal zone lymphoma refractory – Trials in Disease Glomerulonephritis membranous – Treatment Pemphigus – Treatment Congenital nephrogenic diabetes insipidus – Basic Information Acute respiratory distress syndrome – Life with Disease Haemophagocytic lymphohistiocytosis – Basic Information More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Bms-986449-03 Vemircopan Nilotinib GSKVX000000048110 Bms-986442 Morf-057 Specific Nucleic Acid Sna-Papi ATTR-01 TRAZODONE HYDROCHLORIDE Galunisertib Cytisine IMELASOMERAN LTI-03 Keto-Isoleucine Calcium Sodium Zirconium Cyclosilicate Somatostatin Lenograstim Amniotic Membrane, Human VENT-03 Azd2693 Sodium More therapies…

    Learn about Your Condition

    Thymic carcinoma Cholangiocarcinoma Infertility Tachypnoea Vulvovaginal candidiasis Bladder cancer Deep vein thrombosis Breast cancer recurrent Herpes simplex reactivation Papilloma viral infection Synovitis Small intestine leiomyosarcoma Choreoathetosis Right ventricular dysfunction Retroperitoneal fibrosis More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Staphylococcal bacteraemia

  • Safety and Pharmacokinetics of MIB2 (StaphAcute) in Healthy Volunteers and Patients with Staphylococcus aureus Bacteremia

    Recruiting

    2 1 1
    Investigated Drugs:
    • Sodium Chloride
    Germany

  • Study of cefadroxil effectiveness in adult patients with Staphylococcus aureus bloodstream infection

    Recruiting

    2 1 1 1
    Belgium

  • Study on the Effectiveness of Clarithromycin and Other Drug Combinations for Patients with Uncomplicated Staphylococcus aureus Blood Infection

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Staphylococcal bacteraemia
    Investigated Drugs:
    • Cefuroxime Sodium
    • Cloxacillin Sodium
    • Gentamicin
    Denmark

  • Study Comparing Benzylpenicillin and Cloxacillin for Treating Staphylococcus Aureus Blood Infection in Patients

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Staphylococcal bacteraemia
    Investigated Drugs:
    • Benzylpenicillin Sodium
    • Cloxacillin
    Sweden

  • Study on How Kidney Function Estimates Help Adjust Cloxacillin Dosing in Patients with Staphylococcus aureus Bacteremia

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Staphylococcal bacteraemia
    • Staphylococcal infection
    Investigated Drugs:
    • Cloxacillin
    Sweden

  • Study on the Effect of Rifampicin and Drug Combination for Patients with Staphylococcus aureus Bacteremia

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • Benzylpenicillin Sodium
    • Cefalexin
    • Cefazolin
    France Germany The Netherlands Sweden
1 2
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!